novo nordisk news - Search News

Novo Nordisk Stock Rises

5 Questions Novo Nordisk Needs to Answer to Get Its Stock Moving Higher

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of America addresses the company’s earnings and more.

Yahoo · 7h

5 Questions Novo Nordisk Must Answer to Drive Its Stock Higher

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of America addresses the company’s earnings and more.

The Motley Fool · 13d

Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.

SchaeffersResearch.com · 7h

Novo Nordisk Stock Jumps on Upgrade to 'Buy'

Novo Nordisk stock has erased 40.7% over the last six months, worsened by a nearly 20% bear gap back in late December following an update on the company's weight loss drug CagriSema. Now "oversold," NVO's 14-day relative strength index (RSI) ranks at 15.

Yahoo · 14h

Novo Nordisk Needs Answers to These 5 Key Questions

Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental obesity pill, and supply capacity for Ozempic and Wegovy.

Novo Nordisk Expands AI Partnership With Valo Health

MarketWatch on MSN · 9h

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss drug.

Seeking Alpha on MSN · 9h

Novo Nordisk, Valo Health expand drug discovery deal

Novo Nordisk (NVO) and Valo Health expand collaboration to develop new treatments targeting cardiometabolic diseases. Read more here.

Business Insider · 9h

Novo Nordisk Expands Drug Discovery Collaboration With Valo Health For Cardiometabolic Diseases

Under the expanded collaboration, Valo's Opal Computational Platform will be integrated with Novo Nordisk's expertise in cardiometabolic diseases, deriving insights from real-world patient data, conducting trials, and developing therapeutics with human-centric AI small molecule design.

4hon MSN

Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'

Key Takeaways Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts ...

DPA International on MSN7h

Novo Nordisk expands drug collaboration with Valo Health

Denmark's Novo Nordisk on Wednesday announced an expansion of its collaboration with Valo Health to discover and develop ...

FierceBiotech9h

Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes

Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 million in near-term payments—and ...

24/7 Wall St3h

Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals

Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic ...

GEN4h

Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial ...

3hon MSN

This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Novo Nordisk Stock Rises

Novo Nordisk Expands AI Partnership With Valo Health

Related topics